Blanco AN - Search Results

1

Type 2N von Willebrand disease: Is it always a recessive trait?

Woods AI, Rossetti LC, Paiva J, De Brasi CD, Romero ML, Casinelli MM, Blanco AN, Sánchez-Luceros A. Woods AI, et al. Among authors: blanco an. Thromb Res. 2021 Feb;198:49-51. doi: 10.1016/j.thromres.2020.11.029. Epub 2020 Nov 28. Thromb Res. 2021. PMID: 33285477 No abstract available.

2

Congenital factor XIII deficiency associated with von Willebrand disease.

Grand B, Blanco A, Riveros D, Ventura A, Maugeri N, Woods A, Lazzari M. Grand B, et al. Am J Hematol. 1990 Nov;35(3):208-9. doi: 10.1002/ajh.2830350313. Am J Hematol. 1990. PMID: 2220766

3

Visualization of the multimeric structure of von Willebrand factor by immunoenzymatic stain using avidin-peroxidase complex instead of avidin-biotin peroxidase complex.

Farias C, Kempfer AC, Blanco A, Woods A, Lazzari MA. Farias C, et al. Thromb Res. 1989 Mar 1;53(5):513-8. doi: 10.1016/0049-3848(89)90206-5. Thromb Res. 1989. PMID: 2472017 No abstract available.

4

Intraplatelet levels of vWF:Ag and fibrinogen in myeloproliferative disorders.

Meschengieser S, Blanco A, Woods A, Maugeri N, Fernandez J, Dupont J, Lazzari MA. Meschengieser S, et al. Thromb Res. 1987 Nov 1;48(3):311-9. doi: 10.1016/0049-3848(87)90443-9. Thromb Res. 1987. PMID: 3501618

5

Platelet function and intraplatelet von Willebrand factor antigen and fibrinogen in myelodysplastic syndromes.

Meschengieser S, Blanco A, Maugeri N, Dupont J, Fernández J, de Tezanos Pinto M, Lazzari M. Meschengieser S, et al. Thromb Res. 1987 May 15;46(4):601-6. doi: 10.1016/0049-3848(87)90161-7. Thromb Res. 1987. PMID: 3617014 No abstract available.

6

Some questions about acquired inhibitors and bleeding time.

Blanco A, Duplancic M, Peñalva L, Ventura A, Lazzari M. Blanco A, et al. Thromb Res. 1994 Nov 15;76(4):385-9. doi: 10.1016/0049-3848(94)90167-8. Thromb Res. 1994. PMID: 7871497 No abstract available.

7

Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease.

Woods AI, Meschengieser SS, Blanco AN, Salviú MJ, Farías CE, Kempfer AC, Lazzari MA. Woods AI, et al. Among authors: blanco an. Haematologica. 2001 Apr;86(4):420-7. Haematologica. 2001. PMID: 11325650

8

Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: a retrospective analysis by a single institution.

Sánchez-Luceros A, Meschengieser SS, Woods AI, Blanco AN, Kempfer AC, Casais P, Salviú MJ, Lazzari MA. Sánchez-Luceros A, et al. Among authors: blanco an. Haematologica. 2002 Mar;87(3):264-70. Haematologica. 2002. PMID: 11869938

9

Morbidity of lupus anticoagulants in children: a single institution experience.

Casais P, Meschengieser SS, Gennari LC, Alberto MF, Sanchez-Luceros A, Blanco AN, Lazzari MA. Casais P, et al. Among authors: blanco an. Thromb Res. 2004;114(4):245-9. doi: 10.1016/j.thromres.2004.06.006. Thromb Res. 2004. PMID: 15381387

10

von Willebrand disease: laboratory aspects of diagnosis and treatment.

Favaloro EJ, Lillicrap D, Lazzari MA, Cattaneo M, Mazurier C, Woods A, Meschengieser S, Blanco A, Kempfer AC, Hubbard A, Chang A. Favaloro EJ, et al. Haemophilia. 2004 Oct;10 Suppl 4:164-8. doi: 10.1111/j.1365-2516.2004.00979.x. Haemophilia. 2004. PMID: 15479392 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page